Gastroparesis is a chronic gastrointestinal condition that happens when the stomach can’t empty well, causing delayed ...
In patients with T1D, cannabinoid hyperemesis syndrome and diabetic gastroparesis have similar symptoms but different ...
Functional dyspepsia (FD) and gastroparesis (GP) are gastrointestinal disorders often managed as separate conditions. FD is classified as a disorder of gut-brain interaction (DGBI), characterized by ...
A groundbreaking review in eGastroenterology examines the overlap between functional dyspepsia (FD) and gastroparesis (GP), two gastrointestinal disorders traditionally viewed as distinct. New ...
18h
Ultimate Classic Rock on MSNHow Rush’s Alex Lifeson Transformed His Health After 2023 SurgeryAlex Lifeson said he’d felt nauseous for a year after undergoing stomach surgery in 2023. The ex Rush guitarist revealed that ...
"2024 was a transformative year for Evoke Pharma, as we successfully executed on key commercial and strategic initiatives ...
Good afternoon, and welcome to the Evoke Pharma fourth quarter and full-year 2024 earnings conference call. (Operator Instructions) Please be advised that today's call is being recorded. I would now ...
Evoke Pharma, Inc. ( NASDAQ: EVOK) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Daniel Kontoh-Boateng – DKB Partners Matt D’Onofrio – Chief Executive Officer Chris Quesenberry – Chief ...
Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results